Evoworks Bio
Cambridge-based biotechnology company (founded 2023) developing a biomimetic bioreactor platform that enables direct lab-to-production scaling with integrated measurements, aiming to shorten development timelines and enable cGMP clinical production while supporting a range of bioproducts.
Industries
N/A
Products
Scalable bioreactor platform (lab-to-clinic)
A biomimetic bioreactor platform that provides integrated measurement and enables direct scale-up from lab experiments to ~10 L in-lab volumes and onward to cGMP clinical production.
Scalable bioreactor platform (lab-to-clinic)
A biomimetic bioreactor platform that provides integrated measurement and enables direct scale-up from lab experiments to ~10 L in-lab volumes and onward to cGMP clinical production.
Services
Development partnership
Collaborative development engagements to adapt and scale biological processes using the company's platform within customer labs.
Production assistance for clinical manufacturing
Support to transition processes to cGMP-compliant production and integration with CDMO workflows for clinical trial supply.
Development partnership
Collaborative development engagements to adapt and scale biological processes using the company's platform within customer labs.
Production assistance for clinical manufacturing
Support to transition processes to cGMP-compliant production and integration with CDMO workflows for clinical trial supply.
Expertise Areas
- Bioprocess scale-up
- Bioreactor design and engineering
- Process development for fermentation and cell culture
- Process analytical technology (PAT) integration
Key Technologies
- Bioreactor scale-up platforms
- Process analytical technology (PAT)
- Real-time bioprocess sensors
- cGMP manufacturing systems